In addition, GSK3β inhibitor, LY2090314, has been reported to modulate the intrinsic PC cell resistance with chemotherapeutic agents, such as Oxaliplatin and gemcitabine [161]. The gene discussed is GSK3B; the disease is pachyonychia congenita.